FIOCRUZ HIV prevention and treatment center in Rio de Janeiro
Official title: The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
Funded at Fundacao Oswaldo Cruz · NIH-11237053 · Data updated 2026-11-12
This center runs clinical trials of new HIV prevention and treatment approaches for people living with or at risk for HIV in Brazil.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fundacao Oswaldo Cruz NIH-funded |
| Lab location | 1 site (Rio de Janeiro, BRAZIL) |
| Project start | January 15, 2008 |
| Project end | November 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,997,835 |
| NIH project number | 5UM1AI069476-19 |
| Project ID | NIH-11237053 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people living with HIV or people at risk for HIV who can attend study visits at the FIOCRUZ site in Rio de Janeiro and meet specific trial eligibility rules.
✕Less likely to help
People who live far from Rio de Janeiro, who do not meet study eligibility criteria, or who are ineligible because of medical exclusions may not be able to participate or benefit directly.
What this research studies
You would be joining clinical studies run by the FioTrials team at the Oswaldo Cruz Foundation (FIOCRUZ) in Rio de Janeiro, which conducts hospital-based trials following international good‑clinical‑practice standards. The unit recruits people living with HIV and people at risk, and studies new medicines, prevention strategies, and care approaches—sometimes including TB or hepatitis co-infections. Experienced investigators and junior researchers work together to manage study visits, safety monitoring, and laboratory testing for participants. Many trials at this site have supported regulatory approvals and changes in care practices.
Why it matters
Potential benefit: If successful, the work could bring better prevention tools, safer or more effective HIV treatments, and more trial access for people in Brazil.
How similar studies have gone: FIOCRUZ and affiliated networks have run multiple successful HIV and TB trials that informed treatment and prevention and contributed to licensure of new agents.
Where this research is happening
-
Fundacao Oswaldo Cruz
Rio de Janeiro, Brazil Active
Researchers
- Principal investigator: Grinsztejn, Beatriz — Fundacao Oswaldo Cruz
- Study coordinator: Grinsztejn, Beatriz
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
FIOCRUZ HIV/AIDS Clinical Trials Unit: advancing HIV prevention and treatment in Brazil
A Brazilian clinical trials unit led by Dr. Beatriz Grinsztejn is testing and speeding up new HIV prevention and treatment strategies to help people living with HIV/AIDS and those at risk.
-
Breeding colony expansion to support HIV/AIDS research with rhesus macaques
A funding opportunity to expand a specialized Rhesus macaque breeding population to support HIV/AIDS research at Tulane’s primate facility.
-
HIV Resilience Observatory in a rhesus macaque colony expansion
A program to build a rhesus macaque breeding colony and use AI-powered monitoring to study why some HIV/AIDS outcomes differ among individuals with similar backgrounds.
-
Indoor-Outdoor Housing Expansion to Support HIV/AIDS-Related Research
A HIV-focused project at a primate research center will use new indoor/outdoor housing and AI-assisted monitoring to study why people with similar backgrounds can have very different HIV outcomes.
-
Hearing changes in people with HIV and in people without HIV in Tanzania
This project follows people living with HIV and similar individuals in Tanzania to see how hearing and brain function relate over time and whether hearing tests can help predict cognitive changes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.